About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Efficacy and Safety of XP12B in Women With Menorrhagia

NCT00401193·83 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Ferring Pharmaceuticals

Age

18–49

Sex

FEMALE

Healthy volunteers

Not accepted

You may be eligible if

Women with menorrhagia
18-49 years of age
Regularly occurring menstrual periods

You may not be if

History or presence of clinically significant disease or abnormalities that may confound the study
History of bilateral oophorectomy or hysterectomy
Hormone therapy for birth control

The record

StatusCompleted

PhasePhase 3

Taking part304

StartedNov 2006

UpdatedMay 13, 2015

Conditions

Menorrhagia Heavy Menstrual Bleeding

Where83

Investigative Site
Birmingham, Alabama, United States
Investigative Site
Phoenix, Arizona, United States
Investigative Site
Tucson, Arizona, United States

Clareo Health | Efficacy and Safety of XP12B in Women With Menorrhagia